Clinical Trial Update: Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluated transplantation of human neural stem cells in patients with amyotrophic lateral sclerosis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Human neural stem cell transplantation (neural stem cell transplantation)

Snippet

Sponsor: Azienda Ospedaliera Santa Maria, Terni, Italy | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED